<DOC>
	<DOCNO>NCT01359800</DOCNO>
	<brief_summary>Tat key HIV regulatory protein produce early infection , prior virus integration , necessary viral gene expression , cell-to-cell virus transmission disease progression . Previous study natural HIV infection , indicate presence Tat-specific immune response correlate low incidence reduce risk progression AIDS compare anti-Tat negative individual suggest immune response Tat may exert protective role control progression AIDS vivo . On basis mention consideration , present study direct investigate seroprevalence anti-Tat antibody HIV-infected South African patient .</brief_summary>
	<brief_title>Study Assess Seroprevalence Anti-Tat Antibodies HIV-infected Patients</brief_title>
	<detailed_description>This observational , cross-sectional study aim assessing frequency , magnitude quality anti-Tat antibody response antiretroviral ( ARV ) -treated treatment-na√Øve HIV-infected South African adult , explore correlation presence anti-Tat antibody response immunological status participant well presence co-infections HBV , syphilis HPV ( latter female participant ) . The study involve 531 participant provide important information planning , design conduction future therapeutic clinical trial Tat-based HIV vaccine South African individual . This study conduct frame Government-to-Government cooperation program N. AID 8421 , fund Italian Ministry Foreign Affairs-Directorate General Development Cooperation ( MAE-DGCS ) jointly implement Italian Istituto Superiore di Sanita ' ( ISS ) South African Department Health collaboration South African AIDS Vaccine Initiative Medical Research Council ( MRC-SAAVI )</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>HIVinfected individual Aged 1845 year Participants enrol ARVtreated group must treatment le 3 month . Unwillingness consent study inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>HAART</keyword>
</DOC>